戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1   Prevention of CAV progression is a primary therapeutic goal.
2 setting, where reducing patient anxiety is a therapeutic goal.
3 k of thrombosis and/or hemorrhage is a major therapeutic goal.
4 nhibition of A beta 42 production is a prime therapeutic goal.
5 hus, inhibition of A beta release is a prime therapeutic goal.
6 ind of illnesses, and therefore a reasonable therapeutic goal.
7 control of immune cell activation is a major therapeutic goal.
8 restoring their effector activity is a major therapeutic goal.
9 and increasing progranulin levels is a major therapeutic goal.
10 velopment of antiviral drugs to achieve this therapeutic goal.
11 conditions, AF burden reduction emerges as a therapeutic goal.
12 velopment of antiviral drugs to achieve this therapeutic goal.
13 ed myocardium is an unmet yet highly desired therapeutic goal.
14 osis, and restoring iodine uptake is a major therapeutic goal.
15 on and maintenance of remission is a crucial therapeutic goal.
16 ssis to achieve their primary engineering or therapeutic goal.
17  has become widely accepted as the principal therapeutic goal.
18  suggest that AF burden reduction could be a therapeutic goal.
19 nflammation is an important preventative and therapeutic goal.
20 t ACE2 upregulation is viewed as a desirable therapeutic goal.
21 scle, and enhancing this response has been a therapeutic goal.
22 and preservation of cone function is a major therapeutic goal.
23 ence, making relapse prevention an essential therapeutic goal.
24 ment of neoangiogenesis remains a high-value therapeutic goal.
25            Regenerating retinal neurons is a therapeutic goal.
26 idely considered to be an alternative cancer therapeutic goal.
27  the face of aging is a critically important therapeutic goal.
28 ins of bacteria continues to be an important therapeutic goal.
29 nologic tolerance after transplantation is a therapeutic goal.
30 tion and myeloprotection remain an important therapeutic goal.
31 ith increased vascular supply is a desirable therapeutic goal.
32 on in tumors is widely considered a valuable therapeutic goal.
33 hibition of pathological angiogenesis is the therapeutic goal.
34 fications are needed to achieve an efficient therapeutic goal.
35  inhibiting their actions represents a major therapeutic goal.
36 ease, and ischemia reduction is an important therapeutic goal.
37 the pathways regulating these responses is a therapeutic goal.
38 y optimized patients with HF is a worthwhile therapeutic goal.
39 etformin in monotherapy does not achieve the therapeutic goals.
40 ts might need additional treatments to reach therapeutic goals.
41 and practice organization aimed at achieving therapeutic goals.
42 helps define treatment success and long-term therapeutic goals.
43 ide, glucagon and amylin, to achieve desired therapeutic goals.
44 and that this feature could be exploited for therapeutic goals.
45 characteristics designed to achieve specific therapeutic goals.
46 ular delivery, a requirement for a number of therapeutic goals.
47  to fully harness the potential of hESCs for therapeutic goals.
48 ssible and of potential benefit for specific therapeutic goals.
49 e benefits of each, or have considered their therapeutic goals.
50 t groups in proportion of patients achieving therapeutic goals.
51 protein are becoming recognized as important therapeutic goals.
52 placement and photoreceptor rescue are major therapeutic goals.
53 gn of CpG-based products to achieve specific therapeutic goals.
54  of outcome is an essential step in defining therapeutic goals after cardiac arrest.
55         Reducing heteroplasmy is therefore a therapeutic goal and in vivo models in post-mitotic tiss
56                                          The therapeutic goal and mode changed in 22 (7%) and 21 case
57 s in conventional therapy, novel targets and therapeutic goals are the highlights of treatment for ul
58 eople presenting without metastatic disease, therapeutic goals are tumor eradication and preventing r
59 ph-node (SLN) resection can achieve the same therapeutic goals as conventional ALND but with decrease
60  has been touted as a novel cancer-selective therapeutic goal based on the observation of high telome
61 nclusion/exclusion based on trial design and therapeutic goals because of its unique behavior.
62                                       If the therapeutic goals (cardiac index of > 4.5 L/min/m2, oxyg
63 ned as blood pressure that remains above the therapeutic goal despite concurrent use of at least thre
64                                One important therapeutic goal during CNS injury from trauma or demyel
65 inhibition by CSPG-rich scar is an important therapeutic goal for achieving functional recovery after
66 l of mast cell granule exocytosis is a major therapeutic goal for allergic and inflammatory diseases.
67                                          The therapeutic goal for autoimmune diseases is disease anti
68 ng functional beta-cell mass is an important therapeutic goal for both type 1 and type 2 diabetes (1)
69 rvation and expansion of beta-cell mass is a therapeutic goal for diabetes.
70                                     The main therapeutic goal for diabetic retinopathy (DR) is to pre
71   These complementary outcomes represent the therapeutic goal for future investigation in acute GVHD
72 ration of a recombinant protein is a desired therapeutic goal for hepatic enzymopenic disorders such
73                                    The major therapeutic goal for immune thrombocytopenic purpura (IT
74         Induction of tumor cell death is the therapeutic goal for most anticancer drugs.
75              Remodelling adipose tissue as a therapeutic goal for obesity and its complications has a
76  health-related quality of life (HRQOL) is a therapeutic goal for older patients with advanced heart
77  of mutant beta-globin genes has long been a therapeutic goal for patients with beta-thalassemia or h
78                                 An important therapeutic goal for patients with type 2 diabetes is we
79 ng sPLA2-IIA mass is unlikely to be a useful therapeutic goal for preventing cardiovascular events.
80       Inhibiting Abeta generation is a prime therapeutic goal for preventing or treating Alzheimer di
81 g repair mechanism, may be a more attainable therapeutic goal for promoting functional repair after C
82             Inhibition of TF may represent a therapeutic goal for the prevention of thrombotic compli
83                                  The primary therapeutic goal for the treatment of diabetes is mainte
84 hypertrophy, whose inhibition is a long-term therapeutic goal for the treatment of the course of hear
85                                      A major therapeutic goal for type 1 diabetes (T1D) is to induce
86 dous success in achieving the prognostic and therapeutic goals for early prognosis and treatment of v
87 t year and provides an expert opinion of the therapeutic goals for statin therapy.
88 pleted the scleral lens fitting process, and therapeutic goals (improved comfort, ocular surface prot
89           The group agreed that the ultimate therapeutic goal in both CD and UC is to prevent disease
90 that proteinuria reduction is an appropriate therapeutic goal in chronic proteinuric kidney disease.
91        Lowering hyperglycemia is the typical therapeutic goal in clinical medicine.
92  marker for long-term PFS and as a potential therapeutic goal in CLL.
93 ess AR activity as the single most important therapeutic goal in CRPC treatment.
94       Glucagon suppression should be a major therapeutic goal in diabetes.
95  of myelin is an important but still elusive therapeutic goal in many neurological disorders.
96 ropensity to recur and progress, the primary therapeutic goal in patients with high-risk NMIBC is the
97 ted lipid peroxidation, may be an attractive therapeutic goal in PDAC.
98 Enhancing myelin repair remains an important therapeutic goal in primary demyelinating diseases of th
99 ort the role of inhibition of NF-kappaB as a therapeutic goal in RA.
100 s allograft tolerance, is a highly desirable therapeutic goal in solid organ transplantation.
101                                 Therefore, a therapeutic goal in SSD is pharmacologic reactivation of
102  immunologic effects that may be used with a therapeutic goal in the future.
103 osinophilic inflammation has been an elusive therapeutic goal in the management of asthma pathogenesi
104                                            A therapeutic goal in the treatment of certain CNS disease
105               Myelin repair is an unrealized therapeutic goal in the treatment of multiple sclerosis
106 hether progression-free survival is a worthy therapeutic goal in this disease setting.
107  of life raises issues about the appropriate therapeutic goal in treating heart failure.
108 asize the role of insulin sensitization as a therapeutic goal in type 2 diabetes mellitus.
109 ta) has emerged as one of the most important therapeutic goals in Alzheimer's disease.
110 nificant implications with regard to current therapeutic goals in asthma and allergy and suggest that
111  has long been considered one of the primary therapeutic goals in gene therapy treatments for ARDS.
112                                              Therapeutic goals in individuals with lower-risk MDS inc
113                                              Therapeutic goals in people with higher-risk MDS include
114    Furthermore, emphasis on consideration of therapeutic goals in substitute decision-making framewor
115 and histologic remission have emerged as key therapeutic goals in the management of inflammatory bowe
116  activity indices, definitions of remission, therapeutic goals (including mucosal healing) and outcom
117 ptimized treatment strategy in achieving key therapeutic goals, including primary tumor control, meta
118 ese factors will have limited effects if the therapeutic goal is a downmodulation of immune responses
119                                    The ideal therapeutic goal is dental pulp regeneration, which is n
120 es caused by mutations in a single gene, the therapeutic goal is tissue replacement using stem cells
121                                          The therapeutic goal is to normalise tissue exposure to cort
122             In each of these strategies, the therapeutic goal is to re-ignite T-cell immunity, in ord
123                                              Therapeutic goals may include replacing a defective gene
124                    Eradication of HBsAg as a therapeutic goal might facilitate the induction of endog
125 ons of each model against the scientific and therapeutic goal of a prospective preclinical study.
126 ing organ function has emerged as a critical therapeutic goal of care.
127 ion of androgen receptor signaling remains a therapeutic goal of CRPC therapy.
128                                    While the therapeutic goal of generating Fc-fusion proteins has be
129            Our studies support the realistic therapeutic goal of improved night vision for retinal re
130                                          The therapeutic goal of our medicinal chemistry effort was t
131 eatment of intrabony defects is an important therapeutic goal of periodontal therapy.
132 electromyographic biofeedback, achieving the therapeutic goal of reducing joint loading.
133 llenges and opportunities in moving toward a therapeutic goal of regenerative cardiovascular medicine
134                                          The therapeutic goal of regenerative wound healing has remai
135 t modulate atherosclerosis, and validate the therapeutic goal of skewing T responses to atheroscleros
136 al disease control is a clinically important therapeutic goal of surgical intervention, including nod
137                                          The therapeutic goal of these drugs is to target cardiac myo
138 inical problem because of the two concurrent therapeutic goals of bacterial eradication and tissue pr
139 of care and therapeutic indications: the Bio Therapeutic Goals of Cancer Care Model.
140 e (aSAH), requiring timely intervention with therapeutic goals of improving brain perfusion.
141  designing polymeric vectors towards meeting therapeutic goals of in vivo and ex vivo gene therapy.
142 which best reflects a failure to achieve the therapeutic goals of TAVR.
143 riteria, and provide management guidance and therapeutic goals on occurrence of these toxicities.
144 reaching a treatment-free remission is not a therapeutic goal or treatment-free remission is unlikely
145  patient population, dosing regimen, type of therapeutic goals or end points (hemodynamic, or normal
146                  The development of specific therapeutic goals provides a framework for assessments o
147 o the highest acceptable dosage to reach the therapeutic goal, the benefit of reducing the risk of va
148       To effectively match cannabinoids with therapeutic goals, these compounds must be screened for
149 n of this condition may represent a possible therapeutic goal to interfere with the development of th
150 travenous vasodilator has been proposed as a therapeutic goal to reduce cardiac-wall stress and, pote
151      Control of viral replication is a major therapeutic goal to reduce morbidity and mortality from
152      Thus, B cells expressing CD40L can be a therapeutic goal to regulate inflammatory CD8 T cell res
153 n pressure may constitute the most important therapeutic goals to ameliorate secondary neurological d
154 tion of immune competence is one of the main therapeutic goals, we have evaluated reconstitution of t
155                        The time at which all therapeutic goals were first achieved simultaneously or
156                                   The future therapeutic goal will be to treat patients earlier in th
157 oelasticity of airway mucus is an achievable therapeutic goal with P3001 class mucolytic agents.
158 tients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCOR
159 inal photoreceptor layer is lost, and so the therapeutic goal would be to restore vision at this stag

 
Page Top